Celin Sabu is a global clinical research leader with over 17 years of experience advancing transformative therapies across oncology, cell and gene therapy, and immune-mediated diseases. She serves as a senior Global Study Lead in Cell Therapy, directing complex, high-impact clinical trials focused on CAR-T and engineered cell therapies across international development programs.

Throughout her career, Celin has led more than 60 global clinical trials and over 15 investigator-initiated studies, including pivotal CAR-T programs that contributed to FDA approvals of life-saving therapies. Her expertise spans the full clinical development lifecycle, from early development strategy and global feasibility to late-phase execution, regulatory readiness, and real-world evidence generation. She is particularly recognized for operationalizing highly complex studies in hematologic malignancies and solid tumors, where coordination across manufacturing, sites, and patients is critical to success.

Celin’s work sits at the intersection of science, clinical operations, and patient-centric innovation. She has led global initiatives in eConsent implementation, mobile nursing models, decentralized trial elements, patient education tools, and scalable site engagement frameworks, helping modernize how cell therapy trials are designed and delivered worldwide.

In addition to her industry leadership, Celin is an active speaker, mentor, and thought leader in the cell and gene therapy space. She regularly presents at international conferences, chairs global summits, and contributes to peer-reviewed publications focused on accelerating cell therapy trials and improving vein-to-vein operational models. Her contributions have been recognized through multiple Scientific Affairs and Global Medical Delivery excellence awards.

Celin brings a rare combination of deep CAR-T operational expertise, strategic vision, and a human-centered approach to clinical research. She is deeply committed to educating the next generation of clinical researchers and translating complex science into meaningful patient impact, always grounded in the lives behind every protocol.